RJFSA
RGNX icon

Raymond James Financial Services Advisors’s Regenxbio RGNX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$675K Buy
64,338
+1,895
+3% +$23.1K ﹤0.01% 2422
2024
Q2 		$731K Buy
62,443
+5,161
+9% +$80.3K ﹤0.01% 2280
2024
Q1 		$1.21M Sell
57,282
-8,621
-13% -$153K ﹤0.01% 1952
2023
Q4 		$1.18M Sell
65,903
-49,059
-43% -$864K ﹤0.01% 1890
2023
Q3 		$1.89M Buy
114,962
+50,056
+77% +$907K ﹤0.01% 1537
2023
Q2 		$1.3M Buy
64,906
+23,119
+55% +$445K ﹤0.01% 1777
2023
Q1 		$790K Sell
41,787
-2,350
-5% -$52K ﹤0.01% 2059
2022
Q4 		$1M Sell
44,137
-10,798
-20% -$244K ﹤0.01% 1838
2022
Q3 		$1.45M Sell
54,935
-1,259
-2% -$37.4K ﹤0.01% 1608
2022
Q2 		$1.39M Sell
56,194
-3,302
-6% -$82.5K ﹤0.01% 1647
2022
Q1 		$1.98M Buy
59,496
+9,765
+20% +$271K ﹤0.01% 1497
2021
Q4 		$1.63M Buy
49,731
+988
+2% +$33.6K ﹤0.01% 1672
2021
Q3 		$2.04M Buy
48,743
+7,062
+17% +$254K ﹤0.01% 1474
2021
Q2 		$1.62M Buy
41,681
+14,966
+56% +$535K ﹤0.01% 1624
2021
Q1 		$911K Buy
+26,715
New +$1.14M ﹤0.01% 1910
2020
Q1 		– Sell
-12,498
Closed -$512K – 2778
2019
Q4 		$512K Sell
12,498
-9,405
-43% -$372K ﹤0.01% 1973
2019
Q3 		$780K Sell
21,903
-3,525
-14% -$143K ﹤0.01% 1624
2019
Q2 		$1.31M Buy
25,428
+10,753
+73% +$537K 0.01% 1343
2019
Q1 		$841K Buy
14,675
+5,491
+60% +$272K ﹤0.01% 1553
2018
Q4 		$385K Buy
9,184
+4,478
+95% +$263K ﹤0.01% 1841
2018
Q3 		$355K Buy
+4,706
New +$339K ﹤0.01% 2163

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Raymond James Financial Services Advisors's RGNX Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Regenxbio (RGNX) stake by 3% in Q3 2024, buying an estimated $23.1K and bringing the position to 64,338 shares worth $675K. The position accounts for ﹤0.01% of the portfolio, ranked #2422.

Raymond James Financial Services Advisors first reported a position in RGNX in Q3 2018 and has held it in 21 quarters since. The position peaked at $2.04M in Q3 2021. 186 funds tracked by Wall St. Rank hold RGNX as of Q3 2024.

  • Raymond James Financial Services Advisors held 64,338 shares of Regenxbio worth $675K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 1,895 Regenxbio shares in Q3 2024, an estimated $23.1K.
  • Regenxbio made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2422 holding.
  • Raymond James Financial Services Advisors first reported a position in Regenxbio in Q3 2018 and has held it in 21 quarters since.
  • Raymond James Financial Services Advisors's Regenxbio position peaked at $2.04M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.